Beyond Antihistamines: Using Amlexanox for Allergies 

By: Physicians Preference RX

You know the routine. The pollen count climbs, your eyes start to itch, and you reach for an antihistamine. Maybe it takes the edge off. Still, by afternoon you are sneezing again, rubbing your eyes, and wondering why nothing seems to work all the way. 

Here is one reason. Antihistamines deal with histamine after your body has already released it. Before histamine ever reaches its receptors, a cell called the mast cell has to release it. That upstream step explains why some providers use amlexanox for allergies. 

You are far from alone in this struggle. In 2024, 31.7% of U.S. adults reported a diagnosed seasonal allergy, eczema, or food allergy.¹ Many of them keep looking for better support after standard options fall short. This article explains what amlexanox is and how it differs from an antihistamine. It also reviews what the research shows and how a compounding pharmacy prepares it. 

What Is Amlexanox? 

Amlexanox is an older medication that calms inflammation and allergic reactions. In the United States, it was once available as an oral paste called Aphthasol® for recurring canker sores.² Japan took a different path. There, physicians have prescribed oral amlexanox for allergic asthma since 1987.³ Japanese allergy guidelines also recommend it for allergic rhinitis, the medical term for hay fever.³ 

Amlexanox’s commercial paste is no longer sold in the U.S. Still, licensed compounding pharmacies can prepare it with a valid prescription. Physicians Preference Pharmacy makes it into oral capsules for patients whose providers request it. 

Researchers have also revisited this drug. In 2013, a University of Michigan team found that amlexanox blocks two inflammatory enzymes, TBK1 and IKK-ε.⁴ That discovery sparked new interest in its older uses. As a result, allergy support has become one of the most talked-about uses for compounded amlexanox. 

Amlexanox vs. Antihistamines for Allergies 

Think of a mast cell as a tiny water balloon filled with histamine. Mast cells sit in your skin, airways, gut, and nasal lining. When they sense a trigger like pollen, they burst open and release their contents. Scientists call this degranulation.⁵ 

Histamine is the best-known chemical inside that balloon. Yet mast cells also release leukotrienes, prostaglandins, and cytokines. Together, these chemicals can drive swelling, itching, and congestion.⁶ 

An antihistamine is like grabbing a towel after the balloon pops. It blocks histamine from attaching to its receptors, but the spill has already happened. By contrast, a mast cell stabilizer works before the pop. It helps keep the balloon from bursting in the first place.⁵ Amlexanox belongs to this second group. Researchers group it with cromolyn and tranilast, two other drugs that calm mast cells.⁷ 

Feature	Antihistamines	Mast Cell Stabilizers (Such as Amlexanox)
When they act	After histamine release	Before mast cells release their contents
Main target	Histamine receptors	The mast cell itself
Chemicals addressed	Histamine	Histamine plus others, such as leukotrienes
Typical role	Relief of symptoms	Prevention of allergic reactions

You do not always have to choose one or the other. Some prescribers combine both approaches, while others pick one based on your symptoms. Your provider can choose the plan that fits you best. 

How Amlexanox Works for Allergies: 5 Research Findings 

Researchers have studied how amlexanox affects allergic reactions since the 1980s, mostly by looking at how it acts on mast cells. Here are five findings that explain how it acts on the allergic response. 

1. It presses the brake on histamine release.

Inside mast cells, a messenger called cyclic AMP (cAMP) works like a brake pedal. Higher cAMP means less histamine release. In a 1987 study of rat mast cells, amlexanox raised cAMP levels and sharply reduced histamine release.⁸ 

2. It keeps the brake pressed longer.

Your body also makes an enzyme called phosphodiesterase that breaks down cAMP. The same research team found that amlexanox blocks this enzyme.⁸ In other words, it helps cAMP stick around. The authors concluded that both actions work together to raise cAMP in mast cells. 

3. It latches onto proteins linked to the “pop.”

In 1999, Japanese scientists showed that amlexanox binds two calcium-binding proteins called S100A12 and S100A13.⁷ Cromolyn and tranilast bind the same proteins. Therefore, the researchers proposed that these drugs may calm mast cells through a shared target. 

4. It lowers airway-tightening chemicals in human lung tissue.

Here is how mast cells connect to asthma. In allergic asthma, mast cells in the lungs react to a trigger, such as pollen or dust mites. They release histamine and leukotrienes. These chemicals tighten the muscles around the airways, swell the airway lining, and increase mucus.⁶ The result is the wheezing and chest tightness many people with asthma know too well. 

In the lab, researchers studied human lung tissue sensitized to allergens. With amlexanox present, the tissue released less histamine and fewer leukotrienes.⁹ Higher amounts of amlexanox produced a stronger effect. Put simply, fewer of these chemicals means fewer signals telling the airways to tighten. These results come from lung tissue in a lab, an encouraging first step that future studies in people can build on. 

This finding also shows where amlexanox differs from an antihistamine. Antihistamines do nothing about leukotrienes, which is one reason some people still wheeze after taking them. By contrast, amlexanox reduced leukotriene release in this study. In other words, it reaches a part of the allergic response that antihistamines miss. 

5. It may calm “primed” immune cells.

Sometimes your immune cells are already on high alert. A signaling protein called interleukin-3 (IL-3) can make white blood cells release histamine more quickly. In a 1990 study, amlexanox blocked this IL-3 effect in the cells of most of the people with allergies who took part.¹⁰ 

Taken together, these findings show a drug that acts at several points before symptoms start. 

New Research on Amlexanox in Allergic Asthma 

The 2013 enzyme discovery opened a new door for allergy research. In 2019, researchers in Japan studied a danger signal called cyclic GMP-AMP (cGAMP). Damaged cells can release this signal. The team found that cGAMP worsened house dust mite asthma in mice by acting through TBK1.¹¹ 

Next, they tested amlexanox. Giving it by nose or by mouth reduced allergic lung inflammation in these mice.¹¹ Because this was an animal study, it does not prove the same effect in people. Still, it suggests that amlexanox may affect allergic asthma through more than mast cells alone. 

Who Might Ask About Using Amlexanox for Allergies? 

Amlexanox may be a good fit for some people, and your licensed prescriber can help you decide if it suits your needs. You might want to start a conversation with your provider if any of these sound familiar: 

• You take antihistamines, yet seasonal or year-round symptoms keep coming back. 

• Your provider suspects your symptoms involve mast cells, including possible mast cell activation syndrome (MCAS). 

• You live with allergic asthma or hay fever and want to talk with your care team about other options. 

• Your skin or digestive symptoms are bothersome, and your provider thinks histamine may be involved. 

Questions to Ask Your Provider About Using Amlexanox for Allergies 

Walking into an appointment with a short list can make the visit more productive. Consider asking: 

• Could mast cells be contributing to my symptoms? 

• Would a mast cell stabilizer fit with my current medications? 

• How long should I try amlexanox before we review my progress? 

• Which symptoms should I track, and how should I record them? 

Jot down the answers so you and your provider can measure what changes over time. Equally important, notes keep everyone on your care team on the same page. 

One more point deserves emphasis. Amlexanox is a preventive-style therapy. It does not replace epinephrine, a rescue inhaler, or emergency care for a severe reaction. Keep all emergency medications your provider prescribed and use them as directed. 

Daily habits matter, too. For example, some people pair their care plan with a 30-day dietary reset, such as the Body Reboot Challenge. That challenge removes sugar, grains, dairy products, fruit, yeast, and other foods that the body turns into sugar. Ask your provider whether a change like this makes sense for you. 

Why Quality Matters for Compounded Amlexanox 

Since amlexanox is no longer sold commercially in the U.S., compounding is the main way to get it. Physicians Preference Pharmacy has served physicians and patients since 2001. Here is how our team handles amlexanox prescriptions: 

• PCAB accreditation: We follow PCAB-accredited processes for safety and consistency. 

• Testing beyond USP: Our standards exceed the United States Pharmacopeia (USP), with on-site weight testing and third-party lab potency testing. 

• Tight potency range: We test potency to within ±3%, a tighter limit than the standard requires. We believe the more exact the potency, the better and more consistent our patients will feel. 

• Clean formulas: Our capsules contain no unnecessary dyes, fillers, or sweeteners. 

• Pharmacist access: Our pharmacists work directly with you and your provider to answer questions. 

Frequently Asked Questions About Using Amlexanox for Allergies 

Is amlexanox an antihistamine? No. Amlexanox is a mast cell stabilizer. It acts before mast cells release histamine, while antihistamines block histamine after release. 

Can I buy amlexanox in the United States? Not as a commercial product. However, a compounding pharmacy can prepare it when a licensed provider writes a prescription. 

Does amlexanox stop an allergic emergency? No. Amlexanox does not treat anaphylaxis or sudden asthma attacks. Always keep the emergency medications your provider prescribes. 

Talk With a Pharmacist About Amlexanox 

You don’t have to keep guessing about your allergy options. Amlexanox is available by prescription only, so start by talking with your provider. At your next visit, ask whether compounded Amlexanox could fit your allergy care plan. From there, our pharmacists can work alongside your provider to prepare your prescription and answer questions along the way. Have a question before your appointment? Call Physicians Preference Pharmacy at 281-828-9088, and our pharmacists will be happy to help. To learn more about this medication, watch our webinar by Bryana Burken, PharmD, RPh: Compounded Amlexanox: Inflammation, Immunity, Long COVID, & MCAS. 

References 

1. Bottoms-McClain, Lauren, et al. “Diagnosed Allergic Conditions in Adults: United States, 2024.” NCHS Data Brief, no. 545, National Center for Health Statistics, Jan. 2026, doi:10.15620/cdc/174634. 

2. Bell, J. “Amlexanox for the Treatment of Recurrent Aphthous Ulcers.” Clinical Drug Investigation, vol. 25, no. 9, 2005, pp. 555-566. 

3. Dosanjh, Amrita, and Cindy Y. Won. “Amlexanox: A Novel Therapeutic for Atopic, Metabolic, and Inflammatory Disease.” Yale Journal of Biology and Medicine, vol. 93, no. 5, 2020, pp. 759-763. 

4. Reilly, Shannon M., et al. “An Inhibitor of the Protein Kinases TBK1 and IKK-ε Improves Obesity-Related Metabolic Dysfunctions in Mice.” Nature Medicine, vol. 19, no. 3, 2013, pp. 313-321, doi:10.1038/nm.3082. 

5. Finn, Deirdre F., and John J. Walsh. “Twenty-First Century Mast Cell Stabilizers.” British Journal of Pharmacology, vol. 170, no. 1, 2013, pp. 23-37. 

6. Zhang, Tao, et al. “Mast Cell Stabilisers.” European Journal of Pharmacology, vol. 778, 2016, pp. 158-168. 

7. Shishibori, T., et al. “Three Distinct Anti-Allergic Drugs, Amlexanox, Cromolyn and Tranilast, Bind to S100A12 and S100A13 of the S100 Protein Family.” Biochemical Journal, vol. 338, pt. 3, 1999, pp. 583-589. 

8. Makino, H., et al. “Mechanism of Action of an Antiallergic Agent, Amlexanox (AA-673), in Inhibiting Histamine Release from Mast Cells: Acceleration of cAMP Generation and Inhibition of Phosphodiesterase.” International Archives of Allergy and Applied Immunology, vol. 82, no. 1, 1987, pp. 66-71, doi:10.1159/000234292. 

9. National Center for Advancing Translational Sciences. “Amlexanox.” Inxight Drugs, U.S. Department of Health and Human Services, drugs.ncats.io/drug/BRL1C2459K. 

10. Urisu, A., et al. “Inhibitory Action of Amlexanox on Interleukin-3-Induced Enhancement of Histamine Releasability of Human Leukocytes.” Arerugi, vol. 39, no. 10, 1990, pp. 1448-1454. 

11. Ozasa, Koji, et al. “Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor.” Frontiers in Immunology, vol. 10, 2019, article 2212, doi:10.3389/fimmu.2019.02212.